ISECURETRAC CORP Spending and interest coverage
- R&D / revenue · 12 months: Value 8.28%; Formula and calculation Research and development expense / revenue. Period ending 2012-09-30..
- Stock-based compensation / revenue · 12 months: Value 1.47%; Formula and calculation Share-based compensation / revenue. Period ending 2012-09-30..
- Interest coverage · 12 months: Value -0.93×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2012-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 8.28% | Research and development expense / revenue. Period ending 2012-09-30. $662.53K ÷ $8.00M × 100 ≈ 8.28% |
| Stock-based compensation / revenue · 12 months | 1.47% | Share-based compensation / revenue. Period ending 2012-09-30. $117.43K ÷ $8.00M × 100 ≈ 1.47% |
| Interest coverage · 12 months | -0.93× | Operating income ÷ reported interest expense. $-323.82K ÷ $348.22K ≈ -0.93× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 662.53K USD | Research and Development Expense |
| Revenue | 8.00M USD | |
| Stock-based compensation | 117.43K USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -323.82K USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 348.22K USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $662.53K | $8.00M | $117.43K | $-323.82K | $348.22K | 8.28% | 1.47% | -0.93× | Reported |
| 2012-06-30 | $682.42K | $8.83M | $165.97K | $-10.06K | $344.14K | 7.73% | 1.88% | -0.03× | Reported |
| 2012-03-31 | $748.00K | $9.64M | $216.27K | $53.24K | $642.10K | 7.76% | 2.24% | 0.08× | Reported |
| 2011-12-31 | $822.65K | $9.86M | $274.88K | $-294.30K | $912.39K | 8.34% | 2.79% | -0.32× | Reported |
| 2011-09-30 | $860.00K | $9.96M | $297.68K | $-5.26K | $1.15M | 8.64% | 2.99% | -0.00× | Reported |
| 2011-06-30 | $970.47K | $10.10M | $263.86K | $-113.42K | $1.39M | 9.61% | 2.61% | -0.08× | Reported |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $1.12M | $10.64M | $191.08K | $287.26K | $1.29M | 10.53% | 1.80% | 0.22× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.